SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B4 - Prospectus [Rule 424(b)(4)]:
SEC Accession No. 0001193125-18-075324
Filing Date
2018-03-08
Accepted
2018-03-08 16:50:08
Documents
4

Document Format Files

Seq Description Document Type Size
1 424B4 d507211d424b4.htm 424B4 1540507
2 GRAPHIC g507211g22x07.jpg GRAPHIC 52260
3 GRAPHIC g507211g33j28.jpg GRAPHIC 69258
4 GRAPHIC g507211g46m89.jpg GRAPHIC 28325
  Complete submission text file 0001193125-18-075324.txt   1748110
Mailing Address P. O. BOX # 110341 RESEARCH TRIANGLE PARK NC 27709
Business Address 79 T.W. ALEXANDER DRIVE 4501 RESEARCH COMMONS, SUITE 100 RESEARCH TRIANGLE PARK NC 27709 919-213-9835
G1 Therapeutics, Inc. (Filer) CIK: 0001560241 (see all company filings)

IRS No.: 263648180 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B4 | Act: 33 | File No.: 333-223445 | Film No.: 18677134
SIC: 2834 Pharmaceutical Preparations